Effects of opioid receptor agonists on cAMP second messenger system

Acta Pharmacologica Sinica

Volumn 20, Issue 5, 1999, Pages 452-456

  Liu, Jing Gen ^a   Gong, Ze Hui ^a   Qin, Bo Yi ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Adenylate cyclase; Cyclic AMP; Delta opioid receptors; Etorphine; Methadone; Morphine; NG108 15 cells; Opioid related disorders

Indexed keywords

ADENYLATE CYCLASE; BUPRENORPHINE; CYCLIC AMP; DIHYDROETORPHINE; ETORPHINE; FORSKOLIN; METHADONE; MORPHINE; NALOXONE; OPIATE AGONIST; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; HYBRID CELL; MOUSE; NONHUMAN; RAT; REBOUND; SECOND MESSENGER;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; BUPRENORPHINE; CYCLIC AMP; ETORPHINE; GLIOMA; HUMANS; HYBRID CELLS; METHADONE; MORPHINE; NEUROBLASTOMA; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; TUMOR CELLS, CULTURED;

EID: 0033008566     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nestler EJ. Molecular mechanisms of drug addiction. J Neurosci 1992; 12: 2439-50.
2. Collier HOJ, Francis DL. Morphine abstinence is associated with increased brain cyclic AMP. Nature 1975; 255: 159-62.
3. Collier HOJ. Cellular site of opiate dependence. Nature 1980; 283: 625-9.
4. Yu VC, Eiger S, Duan DS, Lameh J, Sadée W. Regulation of cyclic AMP by the μ-opioid receptor in human neuroblastoma SH-SY5Y cells. J Neurochem 1990; 55: 1390-6.
5. Selley DE, Breivogel CS, Childers SR. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol 1993; 44: 731-41.
6. 2 opioid receptors in acute dependence on morphine in mice. J Pharmacol Exp Ther 1993; 265: 1325-7.
7. Musacchio JM, Greenspan DL. The adenylate cyclase rebound response to naloxone in the NG108-15 cells. Neuropharmacology 1986; 25: 833-7.
8. Sharma SK, Klee WA, Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 1975; 72: 3092-6.
9. Childers SR. Opioid receptor-coupled second messenger systems. Life Sci 1991; 48: 1991-2003.
10. Wang DX, Liu YS, Qin BY. Experimental therapeutic effects of dihydroetorphine in morphine dependent rats and monkeys. Chin J Pharmacol Toxicol 1992; 6: 36-40.
11. Brown BL, Albano JDM, Ekins RP, Sgherzi AM. A simple and sensitive saturation assay method for measurement of adenosine 3′ ,5′-cyclic mono-phosphate. Biochem J 1971; 121: 561-2.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-51.
13. Liu ZM, Wang XP, Ge Y, Zhang XB, Sun WL, Sun GK, et al. A preliminary study on the psychic dependence of dihydroetorphine by using ARCI-CV. Chin Bull Drug Depend 1996; 5: 229-33.
14. Qin BY. Research advances of dihydroetorphine from analgesic to detoxification agent. New Drugs Clin Remedies 1993; 12: 119-23.
15. Qin BY, Wang DX, Huang M. The application of dihydroetorphine to detoxification of heroin addicts. Regul Pept 1994; Suppl 1: S293-4.